After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...

Bilen et al. perform a phase 2 single-arm clinical trial of neoadjuvant cabozantinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma, assess efficacy and find ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a subgroup of breast cancer patients, but not the overall study population.

Ukraine-Russia war live: Zelensky hails ‘good chance to end war’ Hegseth shutters Pentagon office that helped leaders plan for possible future wars JD Vance humiliated by boos at Kennedy ...

The Sydney Morning Herald’s political cartoonist, sketches the political unreality.

After the preschool years, kids still like cartoons, but they want something more complex than straightforward messages about friendship and sharing. They like a bit of conflict, some bad guys (who ...